Patients in Illinois starting to receive experimental pancreatic cancer drug: ‘Game changer’
10 news sources are covering this Health story right now — PULSE is tracking how fast it spreads.
Velocity
How fast coverage is spreading — measured hourly from article rate × source diversity. How this works →
The brief
"Patients in Illinois starting to receive experimental pancreatic cancer drug: ‘Game changer’" is generating significant coverage in the Health category, with 10 articles from 10 distinct sources tracked by PULSE so far.
Outlets currently covering the story include Standard-Examiner, Oncodaily, Medscape and OncLive. PULSE measures a story's velocity from how quickly new articles appear and how many independent newsrooms join the coverage.
This brief was generated by PULSE's extractive engine from coverage metadata only. The latest headlines from every source are listed below; the velocity chart shows how the story is developing in real time.
Generated by PULSE's extractive engine from coverage metadata only — no AI-written claims. Updated 47d ago.
Quick answers
Why is "Patients in Illinois starting to receive experimental pancreatic cancer drug: ‘G" trending?
Because 10 independent news sources published 10 articles about it in a short window — a coverage burst PULSE classifies as a trend.
How does PULSE measure this trend?
PULSE scores velocity from the rate of new articles weighted by source diversity, snapshotted hourly. The full method is public on our methodology page.
Is this trend still active?
The status badge on this page updates hourly: rising, peaking, cooling, or archived once coverage stops for 48 hours.
Coverage (10)
- Intermountain Hospitals in Ogden, Layton to be among first to administer new pancreatic cancer drug Standard-Examiner · 50d ago
- Arturo Loaiza-Bonilla: Daraxonrasib Brings New Hope to Pancreatic Cancer Patients Oncodaily · 50d ago
- Pancreatic Cancer Specialists Getting a Jump on Daraxonrasib Medscape · 54d ago
- Cracking the KRAS Code: Daraxonrasib's Practice-Changing Data in Pancreatic Cancer and Beyond OncLive · 54d ago
- Stanford expands access to revolutionary pancreatic cancer drug Stanford Medicine · 54d ago
- New drug delivers promising survival gains in pancreatic cancer News-Medical · 54d ago
- FDA Accepts daraxonrasib Application for RAS-Mutant Pancreatic Cancer The Clinical Trial Vanguard · 54d ago
- Breakthrough Drug Brings Hope to Utah Grandfather with Pancreatic Cancer University of Utah Health · 54d ago
- Letter to the editor: Good news for patients NH Business Review · 54d ago
- Patients in Illinois starting to receive experimental pancreatic cancer drug: ‘Game changer’ Chicago Tribune · 54d ago
Topics
Related trends
Braves vs. Phillies score: Live updates from winner-take-all Game 3 with NLDS spot on the line
1 news sources are covering this Sports story right now — PULSE is tracking how fast it spreads.
Desperate Phillies, Braves forced to turn to unsavory pitching options for elimination wild-card Game 3
3 news sources are covering this Sports story right now — PULSE is tracking how fast it spreads.
NFL, Illinois Gov. JB Pritzker Drop Statements With New Bears Stadium Update
NFL Commissioner Roger Goodell and Illinois Governor JB Pritzker have held high-level meetings regarding the Chicago Bears' pursuit of a new stadium.
Phillies’ Game 3 in Atlanta flexed to nighttime as standalone Wild Card Series matchup
3 news sources are covering this Sports story right now — PULSE is tracking how fast it spreads.
Phillies set pitching plan for Game 3; Braves make head-scratching decision; live updates
The Phillies and Braves face off in a decisive Game 3 Wild Card matchup with pitching plans and starting rotations taking center stage.
Scientists Studied 1,300 Cancer Patients, Then Found a Pattern in the Gut
1 news sources are covering this Health story right now — PULSE is tracking how fast it spreads.